{"disease":{"id":"anthracycline-related-cardiotoxicity-in-breast-cancer","name":"anthracycline related cardiotoxicity in breast cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07254221","title":"Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Shiraz University of Medical Sciences","has_results":false},{"nct_id":"NCT03934905","title":"Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Texas Tech University Health Sciences Center","has_results":false},{"nct_id":"NCT07426913","title":"Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}